Manel Cervantes

995 total citations
8 papers, 503 citations indexed

About

Manel Cervantes is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Manel Cervantes has authored 8 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 2 papers in Virology and 2 papers in Epidemiology. Recurrent topics in Manel Cervantes's work include HIV/AIDS drug development and treatment (3 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Manel Cervantes is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Manel Cervantes collaborates with scholars based in Spain, Mexico and Germany. Manel Cervantes's co-authors include Mariali Palacios-Cruz, Edgar Santos, Montserrat Sala, María José Amengual, Ferrán Segura, María Mercedes Nogueras, Gemma Navarro, Bonaventura Clotet, Lluís Force and Josep Vilaró and has published in prestigious journals such as Viruses, BMC Infectious Diseases and American Journal of Hematology.

In The Last Decade

Manel Cervantes

8 papers receiving 483 citations

Peers

Countries citing papers authored by Manel Cervantes

Since Specialization

Citations

This map shows the geographic impact of Manel Cervantes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manel Cervantes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manel Cervantes more than expected).

Fields of papers citing papers by Manel Cervantes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manel Cervantes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manel Cervantes. The network helps show where Manel Cervantes may publish in the future.

Co-authorship network of co-authors of Manel Cervantes

This figure shows the co-authorship network connecting the top 25 collaborators of Manel Cervantes. A scholar is included among the top collaborators of Manel Cervantes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manel Cervantes. Manel Cervantes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	COVID-19, a worldwide public health emergency 2020 ·Revista Clínica Española (English Edition) ·Mariali Palacios-Cruz, Edgar Santos, Manel Cervantes, (unknown)	165
2	COVID-19, una emergencia de salud pública mundial 2020 ·Revista Clínica Española ·Mariali Palacios-Cruz, Edgar Santos, Manel Cervantes, (unknown)	156
3	CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study 2020 ·Viruses ·Joan Calvet, Jordi Gratacós, María José Amengual, (unknown), Marta Navarro, Amália Moreno, Antonio Berenguer, (unknown), C. Orellana, Manel Cervantes	21
4	Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients 2006 ·AIDS Research and Human Retroviruses ·Anna Bonjoch, Roger Paredes, Peré Domingo, Manel Cervantes, Enric Pedrol, Esteban Ribera, Lluís Force, Josep M. Llibre, Josep Vilaró, David Dalmau, (unknown), (unknown), Àngels Masabeu, Núria Pérez‐Álvarez, Jordi Puig, (unknown), Bonaventura Clotet	28
5	Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more 2006 ·BMC Infectious Diseases ·María Mercedes Nogueras, Gemma Navarro, (unknown), Montserrat Sala, Manel Cervantes, María José Amengual, Ferrán Segura	83
6	Results of a Study of Prolonging Treatment with Pegylated Interferon-α2A plus Ribavirin in HIV/HCV-Coinfected Patients with No Early Virological Response 2006 ·Antiviral Therapy ·Daniel Fuster, Ramón Planas, Juan González, Lluís Force, Manel Cervantes, Josep Vilaró, Mercè Roget, Felipe García, Enric Pedrol, Jordi Tor, (unknown), Anna Salas, Guillem Sirera, Sebastián Videla, Bonaventura Clotet, Cristina Tural	23
7	Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy 2005 ·Antiviral Therapy ·Daniel Fuster, (unknown), Guadalupe Gómez Melis, Ricard Solà, Juan González‐García, Josep Vilaró, Enric Pedrol, Lluís Force, Jordi Tor, Guillem Sirera, Sebastián Videla, Ramón Planas, Bonaventura Clotet, Cristina Tural, (unknown), Manel Cervantes, Felipe García, Mercè Roget	17
8	Neoplasia of plasma cells with atypical presentation and infection by the human immunodeficiency virus. A presentation of two cases 2000 ·American Journal of Hematology ·Susana Herranz, Montserrat Sala, Manel Cervantes, (unknown), (unknown), Ferrán Segura	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact